NASDAQ: LUCD - Lucid Diagnostics Inc.

Altı ay boyunca karlılık: -12.11%
Sektör: Healthcare

Promosyon programı Lucid Diagnostics Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Выручка 0.0005
EBITDA -0.0044
Число акций ао 0.04176 млрд
P/S 375.02
P/BV 3.43
EV/EBITDA 0.0354
Цена ао 0.99
ISIN US54948X1090
Сайт https://www.luciddx.com
Валюта usd
IPO date 2021-10-14
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Günlük fiyat değişimi: -2.3% (0.8291)
Haftalık fiyat değişimi: +3.42% (0.7832)
Aylık fiyat değişimi: +4.15% (0.7777)
3 ayda fiyat değişimi: -1.36% (0.8212)
Altı ayda fiyat değişimi: -12.11% (0.9216)
Yıllık fiyat değişimi: -36.22% (1.27)
Yılbaşından bu yana fiyat değişimi: -37.21% (1.29)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 24.08 1
P/BV -25.3 0
P/E 0 0
EV/EBITDA -1.19 0
Toplam: 3.38

Yeterlik

İsim Anlam Seviye
ROA, % -193.13 0
ROE, % 2278.93 10
Toplam: 3.33

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.3318 10
Toplam: 7.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 385.6 10
karlılık Ebitda, % 945.07 10
karlılık EPS, % 955.46 10
Toplam: 10
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Luminus Management, LLC 773246 1.6
Vanguard Group Inc 332391 0.69
Nantahala Capital Management, LLC 299396 0.62
Bridgeway Capital Management, Inc. 135000 0.28
Geode Capital Management, LLC 131871 0.27
Verition Fund Management, LLC 36166 0.07
Geneos Wealth Management, Inc. 33850 0.07
LPL Financial LLC 32630 0.07
Citadel Advisors Llc 29639 0.06
Blackrock Inc. 23453 0.05



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Lishan Aklog M.D. Chairman & CEO 300k 1966 (58 yıllar)
Dr. Sanford D. Markowitz M.D., Ph.D. Co-Founder, Strategic Advisor & Member of the Medical Advisor Board 14.54k
Dr. Joseph Willis M.D. Cofounder, Strategic Advisor & Member of Medical Advisory Board N/A
Dr. Amitabh Chak M.D. Co-Founder, Strategic Advisor & Member of Medical Advisory Board N/A
Richard D. Yazbeck Chief Technology Officer N/A
Dr. Suman M. Verma M.D., Ph.D. Chief Scientific Officer N/A
Dr. Brian J. deGuzman M.D. Chief Compliance Officer N/A 1965 (59 yıllar)
Mr. Michael Adam Gordon General Counsel & Secretary 250k 1975 (49 yıllar)
Mr. Shaun M. O'Neill M.B.A. President & COO 1982 (42 yıl)
Dr. Deepika A. Lakhani Ph.D. Chief Regulatory & Quality Officer

Adres: United States, New York. NY, 360 Madison Avenue - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.luciddx.com